BRCA1 and breast cancer: With respect to exogenous hormones, Kotsopoulos et al. have reported a significant 40% (OR = 1.40; 0.95% CI 1.14–1.70) increased risk of early-onset (diagnosed before age 40) breast cancer among BRCA1 mutation carriers with ever versus never oral contraceptive use in a case-control study.